OpenAlex
PricingAboutJobs
Log inGet started
Work

Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.

PubMed

Year: 2003
Type: article
Source: PubMed
Authors: Pnina Fishman, Sara Bar-Yehuda, Eti Ardon, Lea Rath-Wolfson, Faina Barrer, Avivit Ochaion, Lea Madi
Institutions: Tel Aviv University, Rabin Medical Center, Can-Fite BioPharma (Israel)
Language: English

Topic: Adenosine and Purinergic Signaling
Subfield: Physiology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: A3 adenosine receptor, IB-MECA, prostate cancer, PC-3 cells, castration-resistant prostate cancer, GSK3β, β-catenin, Wnt signaling, NF-κB, cyclin D1, c-Myc, pKa, tumor growth inhibition, cancer therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2120151913
FWCI: 2.005
Cites: 28
Cited by: 100
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms